Immatics (IMTX) Operating Expenses (2019 - 2025)
Immatics (IMTX) reported Operating Expenses of -$73.7 million for Q4 2025, down 24.54% on a YoY basis from -$97.7 million in Q4 2024, and down 5.32% sequentially from -$70.0 million in Q3 2025.
Immatics (IMTX) Operating Expenses (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Operating Expenses data on file, last reported at -$73.7 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses fell 24.54% year-over-year to -$73.7 million; the trailing twelve-month figure through Dec 2025 stood at -$266.0 million (down 26.34% YoY), and the FY2025 full-year result was -$265.5 million, down 26.11% from the prior year.
- Operating Expenses declined to -$73.7 million in Q4 2025, from -$70.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of -$34.5 million in Q2 2021 to a low of -$73.7 million in Q4 2025.
- A 5-year average of -$47.0 million and a median of -$41.4 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses slumped 86.6% in 2021 and dropped 1.74% in 2022, its largest moves.
- Tracing IMTX's Operating Expenses over 5 years: stood at -$36.4 million in 2021, then slipped by 5.41% to -$38.3 million in 2022, then decreased by 22.44% to -$47.0 million in 2023, then retreated by 26.02% to -$59.2 million in 2024, then dropped by 24.54% to -$73.7 million in 2025.
- Business Quant data shows IMTX's Operating Expenses at -$73.7 million in Q4 2025, -$70.0 million in Q3 2025, and -$65.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | -73.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -73.69 Mn |
| Sep 30, 2025 | -69.97 Mn |
| Jun 30, 2025 | -65.52 Mn |
| Mar 31, 2025 | -56.78 Mn |
| Dec 31, 2024 | -59.17 Mn |
| Sep 30, 2024 | -54.98 Mn |
| Jun 30, 2024 | -48.83 Mn |
| Mar 31, 2024 | -47.53 Mn |
| Dec 31, 2023 | -46.95 Mn |
| Sep 30, 2023 | -42.87 Mn |
| Jun 30, 2023 | -39.94 Mn |
| Mar 31, 2023 | -39.89 Mn |
| Dec 31, 2022 | -38.35 Mn |
| Sep 30, 2022 | -37.30 Mn |
| Jun 30, 2022 | -36.17 Mn |
| Mar 31, 2022 | -38.63 Mn |
| Dec 31, 2021 | -36.38 Mn |
| Sep 30, 2021 | -34.78 Mn |
| Jun 30, 2021 | -34.46 Mn |
| Mar 31, 2021 | -37.97 Mn |